Lipum AB (publ) (LIPUM.ST)

SEK 13.3

(-1.48%)

Gross Profit Summary of Lipum AB (publ)

  • Lipum AB (publ)'s latest annual gross profit in 2023 was 53 Thousand SEK , up 218.18% from previous year.
  • Lipum AB (publ)'s latest quarterly gross profit in 2024 Q3 was -3000.00 SEK , up 75.0% from previous quarter.
  • Lipum AB (publ) reported a annual gross profit of -11 Thousand SEK in annual gross profit 2022, down 0.0% from previous year.
  • Lipum AB (publ) reported a annual gross profit of - SEK in annual gross profit 2021, up 100.0% from previous year.
  • Lipum AB (publ) reported a quarterly gross profit of -3000.00 SEK for 2024 Q3, up 75.0% from previous quarter.
  • Lipum AB (publ) reported a quarterly gross profit of -12 Thousand SEK for 2024 Q2, down 0.0% from previous quarter.

Annual Gross Profit Chart of Lipum AB (publ) (2023 - 2017)

Historical Annual Gross Profit of Lipum AB (publ) (2023 - 2017)

Year Gross Profit Gross Profit Growth
2023 53 Thousand SEK 218.18%
2022 -11 Thousand SEK 0.0%
2021 - SEK 100.0%
2020 -31.73 Million SEK -69.02%
2019 -18.77 Million SEK -986289.74%
2018 -1903.30 SEK 27.36%
2017 -2620.30 SEK 0.0%

Peer Gross Profit Comparison of Lipum AB (publ)

Name Gross Profit Gross Profit Difference
Alligator Bioscience AB (publ) -160.68 Million SEK 100.033%
Ziccum AB (publ) -23.28 Million SEK 100.228%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 346.31 Million SEK 99.985%
Sprint Bioscience AB (publ) 41.78 Million SEK 99.873%
Mendus AB (publ) 28.48 Million SEK 99.814%
Genovis AB (publ.) 54 Million SEK 99.902%
Intervacc AB (publ) -13.79 Million SEK 100.384%
QuiaPEG Pharmaceuticals Holding AB (publ) 2.17 Million SEK 97.559%
Active Biotech AB (publ) -1.67 Million SEK 103.164%
Magle Chemoswed Holding AB (publ) 9.96 Million SEK 99.468%
Bio-Works Technologies AB (publ) 26.82 Million SEK 99.802%
Aptahem AB (publ) 2.63 Million SEK 97.985%
Vicore Pharma Holding AB (publ) -3.42 Million SEK 101.549%
Kancera AB (publ) -1.96 Million SEK 102.697%
Infant Bacterial Therapeutics AB (publ) 77 Thousand SEK 31.169%
Fluicell AB (publ) 1.73 Million SEK 96.951%
Saniona AB (publ) 11.78 Million SEK 99.55%
Lipigon Pharmaceuticals AB (publ) -5.11 Million SEK 101.036%
Biovica International AB (publ) 6.87 Million SEK 99.229%
Spago Nanomedical AB (publ) -23.28 Million SEK 100.228%
AcouSort AB (publ) 8.38 Million SEK 99.368%
Xintela AB (publ) 78 Thousand SEK 32.051%
Abliva AB (publ) -35.66 Million SEK 100.149%
Egetis Therapeutics AB (publ) -146.9 Million SEK 100.036%
Karolinska Development AB (publ) 2.8 Million SEK 98.112%
OncoZenge AB (publ) 3000.00 SEK -1666.667%
Amniotics AB (publ) -1.93 Million SEK 102.746%
2cureX AB (publ) -37.48 Million SEK 100.141%
CombiGene AB (publ) -21.29 Million SEK 100.249%
Asarina Pharma AB (publ) -423 Thousand SEK 112.53%
Calliditas Therapeutics AB (publ) 1.12 Billion SEK 99.995%
Camurus AB (publ) 1.58 Billion SEK 99.997%
Corline Biomedical AB 28.38 Million SEK 99.813%
IRLAB Therapeutics AB (publ) -122.73 Million SEK 100.043%
Isofol Medical AB (publ) -34.41 Million SEK 100.154%
I-Tech AB 27.56 Million SEK 99.808%
Hansa Biopharma AB (publ) 70.95 Million SEK 99.925%
Cyxone AB (publ) 2.61 Million SEK 97.97%
ExpreS2ion Biotech Holding AB (publ) 3.4 Million SEK 98.443%
Biosergen AB -456 Thousand SEK 111.623%
Cantargia AB (publ) -3.45 Million SEK 101.536%
NextCell Pharma AB -43.74 Million SEK 100.121%
Xspray Pharma AB (publ) -9.19 Million SEK 100.576%
Elicera Therapeutics AB (publ) 11.21 Million SEK 99.528%
Nanologica AB (publ) -76 Thousand SEK 169.737%
SynAct Pharma AB -778 Thousand SEK 106.812%
Annexin Pharmaceuticals AB (publ) -193 Thousand SEK 127.461%
Stayble Therapeutics AB (publ) - SEK -Infinity%
LIDDS AB (publ) -12.92 Million SEK 100.41%
BioInvent International AB (publ) 71.46 Million SEK 99.926%
Alzinova AB (publ) 19.87 Million SEK 99.733%
Oncopeptides AB (publ) 36.29 Million SEK 99.854%
Pila Pharma AB (publ) 1.46 Million SEK 96.377%
Guard Therapeutics International AB (publ) -15 Thousand SEK 453.333%
Scandinavian ChemoTech AB (publ) 1.65 Million SEK 96.803%
Simris Alg AB (publ) 2 Million SEK 97.359%
Diamyd Medical AB (publ) -3.58 Million SEK 101.48%
Xbrane Biopharma AB (publ) 35.38 Million SEK 99.85%
Ascelia Pharma AB (publ) -1.04 Million SEK 105.052%
Diagonal Bio AB (publ) 3.13 Million SEK 98.308%